|

Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases

RECRUITINGSponsored by University Hospital, Toulouse
Actively Recruiting
SponsorUniversity Hospital, Toulouse
Started2022-09-05
Est. completion2027-09-01
Eligibility
Age18 Years – 99 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05318196

Summary

Managing patients with renal failure requires an understanding of the molecular mechanisms that lead to its occurrence (i.e. upstream of the disease), its worsening and its persistence (i.e. downstream), while also specifying the risk of worsening renal failure (risk stratification, intolerance to the treatment or complications (infectious, metabolic, cardiovascular, cancer…). Nephrogene 2.0 aims to study these different components of kidney, immune and solid organ transplantation (SOT)-related diseases.

Eligibility

Age: 18 Years – 99 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients (\> 18 year of age) with kidney disease or at risk to develop a kidney disease,
* Patients followed by a practitioner of the Department of Nephrology and Organ Transplantations of the University Hospital of Toulouse (France)

Exclusion Criteria:

* consent deny
* inability of the patient or its family to give consent.

Conditions6

Acute Kidney InjuryCancerChronic Kidney DiseasesImmune DiseasesMetabolic DiseaseSolid-organ Transplantation

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.